EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasmonic Mesoporous Gold‐Based SERS Biosensor for Ovarian Cancer‐Derived Extracellular Vesicles

Javeria Bashir, Mostafa Kamal Masud iD, Asep Sugih Nugraha, Chia-Hung Liu, Arya Vasanth, Aditya Ashok, S M Azad Hossain, Emtiaz Ahmed, Tanja Pejovic, Terry Morgan, John Hooper, Andrew Lai und 5 weitere

Small · 2025-08 · 21 (34)

DOI: 10.1002/smll.202401817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 09.07.2025. Verfasst von Javeria Bashir und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Mechanical and Mining Engineering, Faculty of Engineering, Architecture, and Information Technology (EAIT), The University of Queensland, B…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Ovarian Neoplasms, Spectrum Analysis, Raman, Gold. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation Cancer Research Fellowship, JST-ERATO Materials Space-Tectonics Project, ARC Australian Laureate Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are lipids bilayer‐delimited particles carrying bioactive molecules such as proteins, lipids, and nucleic acids, reflecting the physiological state of their origin. Found in biofluids like saliva, urine, blood, and peritoneal fluid, EVs serve as promising minimally invasive biomarkers for several conditions including cancer. However, achieving high sensitivity and specificity in EV detection remains technically challenging. Placental Alkaline Phosphatase (PLAP), an enzyme primarily expressed in the placenta during pregnancy, has emerged as a clinically relevant biomarker in gynecological malignancies, including ovarian cancer (OC). In this study, a nanoengineered mesoporous gold (mAu)‐based Surface‐Enhanced Raman Spectroscopy (SERS) platform is reported for the rapid and ultrasensitive detection of PLAP‐positive EVs in OC patients. The mAu offers high surface roughness, enabling numerous localized plasmonic hotspots that amplify Raman signals and improve probe and antibody loading. This allowed the detection of as few as 100 EVs mL −1 with excellent reproducibility (RSD < 5%,n = 3). In clinical validation (n = 30), the assay achieved 90% sensitivity ( 95% CI: 60%–100%) and 85% specificity ( 95% CI: 15%–100% ) in distinguishing OC patients from those with benign and healthy controls, demonstrating superior performance compared to CA‐125. The mAu‐SERS platform shows considerable promise as a minimally invasive and clinically applicable diagnostic strategy for OC, especially for differential diagnosis for their ability to distingluis between benign and OC conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesOvarian NeoplasmsSpectrum Analysis, RamanGoldBiosensing TechniquesFemaleHumansPorosity

Stichwörter der Autor:innen

extracellular vesiclesliquid biopsymesoporous goldovarian cancersurface‐Enhanced Raman Spectroscopy (SERS)

Substanzen

Gold

Autor:innen und Institutionen

  • School of Mechanical and Mining Engineering, Faculty of Engineering, Architecture, and Information Technology (EAIT), The University of Queensland, Brisbane, Queensland, 4072, Australia.
  • Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland, 4072, Australia.
  • TMU Research Center of Urology and Kidney and Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei, 11031, Taiwan.
  • Department of Urology, Shuang Ho Hospital, Taipei Medical University, 291 Zhongzheng Road, Zhonghe District, New Taipei City, 23561, Taiwan.
  • Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, 97239-3098, USA.
  • Department of Pathology, Oregon Health & Science University, Portland, OR, 97239-3098, USA.

ORCID-Profile: Mostafa Kamal Masud, Yusuke Yamauchi

Förderung

  • Next Generation Cancer Research Fellowship
  • JST-ERATO Materials Space-Tectonics Project
  • ARC Australian Laureate Fellowship
  • Advance Queensland Fellowship Program
  • Medical Research Future Fund
  • National Health and Medical Research Council
  • Donald & Joan Wilson Foundation Ltd.
  • Ovarian Cancer Research Foundation

Zitieren

APA

Bashir, J., Masud, M. K., Nugraha, A. S., Liu, C. H., Vasanth, A., Ashok, A., Hossain, S. M. A., Ahmed, E., Pejovic, T., Morgan, T., Hooper, J., Lai, A., Guanzon, D., Kaneti, Y. V., Hossain, M. S. A., Salomon, C., & Yamauchi, Y. (2025). Plasmonic Mesoporous Gold‐Based SERS Biosensor for Ovarian Cancer‐Derived Extracellular Vesicles. Small, 21(34). https://doi.org/10.1002/smll.202401817

Vancouver

Bashir J, Masud MK, Nugraha AS, Liu CH, Vasanth A, Ashok A, et al. Plasmonic Mesoporous Gold‐Based SERS Biosensor for Ovarian Cancer‐Derived Extracellular Vesicles. Small. 2025;21(34). doi:10.1002/smll.202401817

BibTeX
@article{Bashir2025,
  author = {Bashir, Javeria and Masud, Mostafa Kamal and Nugraha, Asep Sugih and Liu, Chia-Hung and Vasanth, Arya and Ashok, Aditya and Hossain, S M Azad and Ahmed, Emtiaz and Pejovic, Tanja and Morgan, Terry and Hooper, John and Lai, Andrew and Guanzon, Dominic and Kaneti, Yusuf Valentino and Hossain, Md Shahriar A and Salomon, Carlos and Yamauchi, Yusuke},
  title = {Plasmonic Mesoporous Gold‐Based SERS Biosensor for Ovarian Cancer‐Derived Extracellular Vesicles},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {34},
  doi = {10.1002/smll.202401817}
}
Kostenlos starten →